Gemcitabine News and Research

RSS
Gemcitabine is the active ingredient in a drug that is used to treat pancreatic cancer that is advanced or has spread. It is also used together with other drugs to treat breast cancer that has spread, advanced ovarian cancer, and non-small cell lung cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. Gemcitabine blocks the cell from making DNA and may kill cancer cells. It is a type of antimetabolite
Discovery of critical marker of response to gemcitabine in pancreatic cancer

Discovery of critical marker of response to gemcitabine in pancreatic cancer

Trial results show better survival for gallbladder and bile duct cancer

Trial results show better survival for gallbladder and bile duct cancer

New research sheds light on ways to improve treatment for aggressive breast cancer

New research sheds light on ways to improve treatment for aggressive breast cancer

Scientists shed new light on why pancreatic cancer drugs can fail

Scientists shed new light on why pancreatic cancer drugs can fail

New therapy for pancreatic cancer achieves tumor remission and prevents recurrence

New therapy for pancreatic cancer achieves tumor remission and prevents recurrence

Experimental insulin-like growth factor receptor inhibitor a clear clinical candidate for pancreatic cancer therapy

Experimental insulin-like growth factor receptor inhibitor a clear clinical candidate for pancreatic cancer therapy

Rexahn Pharmaceuticals starts phase II pancreatic cancer trial

Rexahn Pharmaceuticals starts phase II pancreatic cancer trial

New trial targets kidney cancer drug sorafenib in bladder cancer

New trial targets kidney cancer drug sorafenib in bladder cancer

Scientists use non-invasive approach to watch chemo drug working inside the living body in real time

Scientists use non-invasive approach to watch chemo drug working inside the living body in real time

Variations in mismatch repair genes predict prognosis in pancreatic cancer

Variations in mismatch repair genes predict prognosis in pancreatic cancer

Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer

Nonhormonal treatment regimens improve survival in patients with metastatic breast cancer

Protein enzyme BubR1 provides new understanding of processes behind cancer-cell survival and drug-resistance

Protein enzyme BubR1 provides new understanding of processes behind cancer-cell survival and drug-resistance

New drug substantially extends survival in pancreatic cancer

New drug substantially extends survival in pancreatic cancer

OncoGenex Pharmaceuticals' OGX-011 granted FDA fast track status

OncoGenex Pharmaceuticals' OGX-011 granted FDA fast track status

Gemcitabine with bevacizumab and radiotherapy safe for pancreatic cancer patients

Gemcitabine with bevacizumab and radiotherapy safe for pancreatic cancer patients

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

Combining sorafenib with carboplatin/paclitaxel adds no benefit in lung cancer

Combining sorafenib with carboplatin/paclitaxel adds no benefit in lung cancer

Multiple studies demonstrate use of hyperthermia therapy in treating pancreatic cancer

Multiple studies demonstrate use of hyperthermia therapy in treating pancreatic cancer

Genentech updates on phase III study of Avastin plus chemo in first-line, advanced, non-squamous, non-small cell lung cancer

Genentech updates on phase III study of Avastin plus chemo in first-line, advanced, non-squamous, non-small cell lung cancer

Drugs in the pipeline: new therapies that could change treatment strategies

Drugs in the pipeline: new therapies that could change treatment strategies